OBJECTIVE:
To investigate whether implementing a bundle, defined as a set of evidence-based practices performed collectively, can reduce 30-day surgical site infections.
METHODS:
Baseline surgical site infection rates were determined retrospectively for cases of open uterine cancer, ovarian cancer without bowel resection, and ovarian cancer with bowel resection between January 1, 2010, and December 31, 2012, at an academic center. A perioperative bundle was prospectively implemented during the intervention period (August 1, 2013, to September 30, 2014). Prior established elements were: patient education, 4% chlorhexidine gluconate shower before surgery, antibiotic administration, 2% chlorhexidine gluconate and 70% isopropyl alcohol coverage of incisional area, and cefazolin redosing 3-4 hours after incision. New elements initiated were: sterile closing tray and staff glove change for fascia and skin closure, dressing removal at 24-48 hours, dismissal with 4% chlorhexidine gluconate, and follow-up nursing phone call. Surgical site infection rates were examined using control charts, compared between periods using x 2 or Fisher exact test, and validated against the American College of Surgeons National Surgical Quality Improvement Program decile ranking.
RESULTS:
The overall 30-day surgical site infection rate was 38 of 635 (6.0%) among all cases in the preintervention period, with 11 superficial (1.7%), two deep (0.3%), and 25 organ or space infections (3.9%). In the intervention period, the overall rate was 2 of 190 (1.1%), with two organ or space infections (1.1%). Overall, the relative risk reduction in surgical site infection was 82.4% (P5.01). The surgical site infection relative risk reduction was 77.6% among ovarian cancer with bowel resection, 79.3% among ovarian cancer without bowel resection, and 100% among uterine cancer. The American College of Surgeons National Surgical Quality Improvement Program decile ranking improved from the 10th decile to first decile; risk-adjusted odds ratio for surgical site infection decreased from 1.6 (95% confidence interval 1.0-2.6) to 0.6 (0.3-1.1).
CONCLUSION: Implementation of an evidence-based surgical site infection reduction bundle was associated with substantial reductions in surgical site infection in high-risk cancer procedures. S urgical site infection is a significant cause of patient morbidity and mortality as well as increased health care costs. [1] [2] [3] The high-complexity surgery often required to cytoreduce ovarian cancer carries a substantial risk for surgical site infection, which is associated with worse overall survival. 4 For patients with uterine cancer, staging performed through laparotomy, rather than a minimally invasive approach, increases the risk of surgical site infection 15-fold. 5, 6 With the feedback of validated outcomes data provided by the American College of Surgeons National Surgical Quality Improvement Program, the Centers for Medicaid and Medicare Services initiated the Surgical Care Improvement Project to reduce surgical complications. 7 Despite high compliance to guidelines for perioperative antibiotic administration, hair removal, normothermia, and glucose control, 1,7 these interventions alone have not been proven to lower surgical site infection rates, 8 which suggests additional interventions are needed.
Surgical site infection risk can be complex with many risk factors that may or may not be modifiable, and there may not be adequate time to address modifiable risk factors. Therefore, perioperative bundles of evidence-based practices performed collectively and designed to reduce surgical site infections have been introduced. [9] [10] [11] [12] [13] The effect of bundled interventions has not been reported in high-risk gynecologic cancer surgeries. Our aim was to evaluate whether implementing a bundle of interventions that spans the entire surgical encounter, modeled after Cima et al, 13 could reduce 30-day surgical site infection rates by 50% in high-risk gynecologic cancer operations.
MATERIALS AND METHODS
The Mayo Clinic, Rochester campus is a large academic center and its Division of Gynecologic Surgery has eight board-certified gynecologic oncology surgeons, including one who retired during the preintervention period. All surgical site infections are captured by Mayo Clinic Infection Prevention and Control, which submits institutional surgical site infection data to the Centers for Medicaid and Medicare Services and the Centers for Disease Control and Prevention's National Healthcare Safety Network. The Mayo Clinic also participates in the multispecialty American College of Surgeons National Surgical Quality Improvement Program.
A multidisciplinary team was assembled to retrospectively evaluate baseline surgical site infection outcomes among gynecologic surgery procedures. Despite long-term Surgical Care Improvement Project measure compliance, 13 the greatest proportion of surgical site infections in our specialty occurred among patients undergoing hysterectomy for gynecologic cancer. An intervention bundle previously shown to decrease surgical site infection in colorectal surgery 13 was selected, adapted, and implemented in gynecologic surgery as a prospective practice change using the Define, Measure, Analyze, Improve, and Control approach to data-driven improvement. 14 This project was reviewed by the Mayo Clinic institutional review board and, as a quality improvement project, was deemed exempt for initial implementation. However, institutional review board approval was obtained retrospectively for publication of findings. Only patients with consent to use their medical records, in accordance with the Minnesota Statute for Use of Medical Information in Research, were included in the published analyses. All laparotomies for ovarian cancer, including primary staging or debulking, interval debulking, and surgery for recurrent disease, and all total abdominal hysterectomies for primary uterine cancer performed during the project timeline were identified. Ovarian cancer cohorts encompassed all histologies and included epithelial ovarian, primary peritoneal, and fallopian tube cancers as well as sex cord-stromal tumors, germ cell tumors, carcinosarcoma, and borderline tumors. Individual patient encounters were used, because patients with recurrent ovarian cancer may undergo multiple surgeries over the course of their disease. The uterine cancer cohort also encompassed all histologies: endometrial carcinoma, carcinosarcoma, endometrial stromal sarcoma, and uterine leiomyosarcoma. Cases were categorized into the following three cohorts for analysis: 1) staging laparotomy for uterine cancer, 2) ovarian cancer debulking not requiring bowel resection, and 3) ovarian cancer debulking with bowel resection.
Cohorts and 182.8. Each encounter was manually and independently verified by three authors (M.P.J., S.J.K., and J.N.B.-G.) to ensure criteria for both diagnosis and surgical procedure were met. Patient and cancer demographics and perioperative risk factors were abstracted for all three cohorts.
Surgical site infections were defined according to the Centers for Disease Control and Prevention's National Healthcare Safety Network category 1B criteria as superficial, deep, and organ or space. 15 Thirtyday surgical site infection data were obtained from the institution's infection prevention and control division. This division is a separate entity from the division of gynecologic surgery, where a dedicated group of infectious disease specialists independently abstracts, reviews, classifies, and validates all potential surgical site infections through review of microbiology reports, readmission diagnoses, surgical listing, and reports from outside institutions on both inpatient and outpatient procedures (category IB). 15 This project used existing data that are part of an established hospital surveillance program within which reporting methodology did not change throughout its course.
The surgical site infection reduction bundle consisted of 15 processes throughout the surgical encounter, including preoperative, intraoperative, postoperative, and postdismissal elements (Box 1). Elements in place during the preintervention period included: patient education on surgical site infection prevention, Hibiclens (4% chlorhexidine gluconate) shower before surgery, prophylactic antibiotic administration, ChloraPrep (2% chlorhexidine gluconate and 70% isopropyl alcohol) coverage of incisional area, and redose of cefazolin within 3-4 hours after incision. New components initiated during the intervention period were: sterile closing tray for fascia and skin closure, staff glove change (and gown if soiled) before fascia closure, dressing removal between 24 and 48 hours, dismissal with 4% chlorhexidine gluconate, and follow-up phone call from nurses.
All patients undergoing gynecologic surgery are managed with an enhanced recovery protocol. 16 An established system to maintain normothermia is in place, hair is removed only when indicated, and blood glucose in diabetics is monitored throughout the perioperative period by a diabetes care team. Aside from standardized bundle elements and these institutional protocols, other perioperative care measures were surgeon-dependent.
Performance metrics on tracked bundle elements (9/15) were collected during audits of electronic medical record documentation. Random audits of the nursing elements were incorporated into routine weekly perioperative nursing care reviews and included providing the patient education pamphlet, hand hygiene, dressing removal, 4% chlorhexidine gluconate showering after dressing removal, dismissal with 4% chlorhexidine gluconate, postoperative patient education on wound care and infection symptoms, and follow-up phone call. Antibiotic compliance and cefazolin redosing were audited by the inpatient pharmacy for all cases.
The preintervention period spanned January 1, 2010, through December 31, 2012. This period established baseline surgical site infection rates for 
, where n i is the number of encounters per month. Odds ratios and corresponding 95% confidence intervals (CIs) were estimated using logistic regression models for the odds of having a surgical site infection in the intervention period compared with the odds in the preintervention method. Adjusted odds ratios were obtained using stabilized inverse probability weights that were stabilized according to the proportion of procedures in the two time periods. The inverse probability weights were derived from a separate logistic regression model of the probability of being in the intervention period (compared with the preintervention period) that included the patient, procedure, and cancer characteristics listed in Tables 1  and 2 and trimmed at the 99th percentile. The covariate balance between the two periods was evaluated by calculating standardized differences for each of the covariates in both the original and weighted cohorts. 17 Analyses were performed using SAS 9.3. All calculated P values were two-sided and those ,.05 were considered statistically significant.
Mayo Clinic Rochester gynecologic surgery patients are identified and charts abstracted each month according to the National Surgical Quality Improvement Program's standard sampling methodology. Their semiannual report decile rankings and odds BMI, body mass index; ASA, American Society of Anesthesiologists; MET, metabolic equivalent of task; UC, uterine cancer; OC, ovarian cancer; BR, bowel resection; TAH, total abdominal hysterectomy. Data are mean6standard deviation or n (%) unless otherwise specified. * x 2 or Fisher exact P value presented for categorical variables and two-sample t test P value presented for continuous variables.
ratios (the odds of a surgical site infection at our site compared with the odds at the "average" site enrolled in the program), adjusted for variables contemporary to each corresponding reporting period, were reported for the project time frame to serve as an additional validation measure.
RESULTS
A total of 825 cases that met criteria for this study were identified: 635 cases in the preintervention period and 190 cases in the intervention period. Compliance with nursing bundle elements was 97.6%. Surgical Care Improvement Project and cefazolin redosing compliance was 95.3%. Baseline patient characteristics are listed in Table 1 . Cohort characteristics for uterine and ovarian cancer are listed in Table 2 . Patient demographics were relatively well balanced between the preintervention and intervention periods with no difference in age, body mass index, American Society of Anesthesiologists class, diabetes, or smoking status. There was a higher proportion of ovarian cancer cases and longer operative times during the intervention period (Table 1) . Among the uterine cancer cohort, there was a higher proportion of advanced-stage disease, sarcoma, and residual disease within the intervention period. Among those with ovarian cancer, there was a lower proportion of early-stage disease and a higher rate of suboptimal debulking (greater than 1 cm residual disease) during the intervention period ( Table 2) .
The baseline overall surgical site infection rate during the preintervention period was 6.0%. After implementation of the reduction bundle, the overall surgical site infection rate declined to 1.1% (P5.01) (Fig. 1) . Among ovarian cancer without bowel resection, the overall surgical site infection rate dropped from 4.8% to 1.0% for a relative risk reduction of 79.3% (P5.12). The overall surgical site infection rate among ovarian cancer with bowel resection decreased from 10.6% to 2.4% for a relative risk reduction of 77.6% (P5.19). Among hysterectomy for uterine cancer, the overall surgical site infection rate declined from 5.1% to 0.0% (P5.23), despite the fact that patients were more likely to have advanced-stage uterine cancer in the intervention group. The relative risk reduction for superficial incisional surgical site infections was 100% (1.7-0.0% P5.08) (Fig. 2A) . The organ and space surgical site infection relative risk reduction was 73.3% (3.9-1.1%; P5.05) (Fig. 2B) . Among ovarian cancer without bowel resection, the rate declined from 3.0% to 1.0% (P5.45), ovarian cancer with bowel resection from 8.8% to 2.4% (P5.29), and among uterine cancer from 2.8% to 0.0% (P5.60). There were only two deep incisional surgical site infections within the project, both of which occurred in cases of ovarian cancer without bowel resection in the preintervention group.
Overall the odds of having a surgical site infection in the intervention period relative to the preintervention period were 0.17 (95% CI 0.04-0.70) ( Table 3 ). The adjusted odds ratio, derived using inverse probability weighting, was similar at 0.13 (95% CI 0.03-0.71) Inverse probability weighting was used to create a weighted sample in which the distributions of measured baseline covariates were more similar between the two time periods. The distribution of the stabilized weights was acceptable (mean 0.99, standard deviation 0.38, range 0.29-2.83). All of the levels of the covariates in the weighted sample had standardized differences below the recommended threshold of 0.10 with the exception of two (operative time 0.135; stage I and II 0.113).
Among all gynecologic surgery cases performed at Mayo Clinic Rochester, the National Surgical Quality Improvement Program surgical site infection decile ranking improved from the 10th decile (preintervention period [January 1, 2012, to December 31, 2012]) to the first decile (April 1, 2013, to March 31, 2014) after implementing the bundle; likewise, the risk-adjusted odds ratio for surgical site infection decreased from 1.6 (95% CI 1.0-2.6) to 0.6 (95% CI 0.3-1.1) during the same time periods.
DISCUSSION
Surgical site infection is a key factor in the vitally important measures of patient morbidity and mortality. After bundle implementation, our overall rate of surgical site infection decreased significantly, exceeding our goal and supporting this institutional practice change.
Several bundles designed to reduce surgical site infection have been reported with similar results. In 2013, van der Slegt et al 12 observed a 51% surgical site infection reduction in vascular surgery cases on implementation of a four-component bundle, which included hair removal, prophylactic antibiotics, normothermia, and operating room discipline. In 2014, Waits et al 9 attained a 2.0% risk-adjusted rate in colorectal surgery after implementing a bundle of prophylactic antibiotics, normothermia, oral antibiotics with bowel preparation, glycemic control, minimally invasive surgery, and short operative duration. They illustrated an inverse association between number of bundle elements implemented and risk-standardized surgical site infection rate, strengthening the bundle concept. Cima et al 13 then adopted a bundle resulting Unauthorized reproduction of this article is prohibited.
in a significant decline of overall surgical site infection rate from 9.8% to 4.0% in colorectal surgery. We chose this bundle for implementation because approximately 40% of our ovarian cancer surgeries require bowel resection. 18 We demonstrated statistically significant reductions when comparing overall surgical site infection rates. However, improvements were not significant among subanalyses by procedure or infection classification as a result of small sample sizes. Among the ovarian cancer without bowel resection subgroup, we would have needed an intervention sample size equivalent to the preintervention size of 269 to have had 80% power to declare the observed difference statistically significant. Among ovarian cancer with bowel resection, a sample size of 125 per period would be needed. Nevertheless, we consider the improvement clinically relevant and note it occurred despite the intervention group having a higher rate of ovarian cancer with bowel resection, advanced uterine cancer, longer operative times, and a smaller proportion of stage I disease.
Strengths of this quality improvement project include its multidisciplinary approach and the independent identification and reporting of infections by both the infection prevention and control division and National Surgical Quality Improvement Program. The reporting methodologies for those two groups were the same for both periods, and abstractors were blinded to when the intervention period began. This may have limited the Hawthorne effect. 19 Additionally, sustained reduction in surgical site infection rates over the 14 months after bundle implementation suggests that results are attributable to the process rather than reactive health care provider effort. Furthermore, we used high-volume and high-risk cases to determine intervention effectiveness. However, we did not eliminate surgical site infection from our practice. The effect of the bundle on surgical site infection rates among other at-risk procedures and patient populations is needed. An additional limitation was that there were differences in patient characteristics between preintervention and intervention groups. On using inverse probability weighting to adjust for the imbalance in SSI, surgical site infection; RRR, relative risk reduction; OR, odds ratio; CI, confidence interval; OC, ovarian cancer; BR, bowel resection; UC, uterine cancer; TAH, total abdominal hysterectomy. Data are % (n/N) unless otherwise specified. * x 2 or Fisher exact P value. † The OR represents the odds of having an SSI in the intervention period compared with the odds in the preintervention period. The adjusted ORs were obtained using stabilized inverse probability weights. ‡ Did not estimate the OR given the lack of events in the intervention period.
the measured covariates, the unadjusted and adjusted odds ratios were similar for all procedures combined.
The one-time cost to build a resterilizable closing pan was $758.34. However, this quality improvement project did not include a cost analysis, and bundle cost-effectiveness warrants further study. Additional limitations include that we do not know surgical site infection rates for the 7-month planning for implementation period and that compliance of patientdependent elements was not quantified.
Further means for improving surgical site infection rates are emerging. Preoperative eradication of methicillin-resistant Staphylococcus aureus colonization has been shown to decrease surgical site infection rates, [20] [21] [22] and we have previously identified prior infection to be an independent risk factor of surgical site infection in endometrial cancer surgery. 6 Prophylactic negative pressure wound therapy has also been shown to reduce abdominal wound surgical site infection rates by up to 70%. 23, 24 Finally, oral antibiotic administration has been shown in retrospective studies to decrease surgical site infection rates in colorectal surgery. [25] [26] [27] However, less than 50% of patients undergoing surgery for ovarian cancer require a bowel resection, and the risks of oral antibiotics with mechanical bowel preparation need to be weighed against the benefits of surgical outcomes.
